Carlos Jiménez-Gutiérrez

785 total citations · 1 hit paper
18 papers, 508 citations indexed

About

Carlos Jiménez-Gutiérrez is a scholar working on Pulmonary and Respiratory Medicine, Pharmacy and Molecular Biology. According to data from OpenAlex, Carlos Jiménez-Gutiérrez has authored 18 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Pharmacy and 3 papers in Molecular Biology. Recurrent topics in Carlos Jiménez-Gutiérrez's work include Infant Health and Development (4 papers), Respiratory and Cough-Related Research (3 papers) and Pediatric health and respiratory diseases (3 papers). Carlos Jiménez-Gutiérrez is often cited by papers focused on Infant Health and Development (4 papers), Respiratory and Cough-Related Research (3 papers) and Pediatric health and respiratory diseases (3 papers). Carlos Jiménez-Gutiérrez collaborates with scholars based in Mexico, United States and Spain. Carlos Jiménez-Gutiérrez's co-authors include Pedro Gutiérrez‐Castrellón, Gabriel López‐Velázquez, Irma Jiménez–Escobar, A.T. Abreu y Abreu, Jordi Espadaler, Javier Mancilla-Ramı́rez, Mohammed Eslam, Nahúm Méndez‐Sánchez, Jacob George and Flavia Indrio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Nutrients.

In The Last Decade

Carlos Jiménez-Gutiérrez

18 papers receiving 488 citations

Hit Papers

Probiotic improves sympto... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Jiménez-Gutiérrez Mexico 12 148 107 104 95 89 18 508
Bernadeta Patro-Gołąb Poland 14 104 0.7× 116 1.1× 115 1.1× 373 3.9× 196 2.2× 28 983
B. Zalewski Poland 14 65 0.4× 108 1.0× 48 0.5× 310 3.3× 199 2.2× 33 925
Liene Bervoets Belgium 14 644 4.4× 80 0.7× 93 0.9× 140 1.5× 93 1.0× 19 1.1k
Ahmadreza Soroush Iran 16 345 2.3× 79 0.7× 48 0.5× 68 0.7× 43 0.5× 37 743
Tom Marrs United Kingdom 17 103 0.7× 66 0.6× 25 0.2× 73 0.8× 135 1.5× 33 1.5k
Christine Barthow New Zealand 17 555 3.8× 267 2.5× 42 0.4× 231 2.4× 126 1.4× 32 1.2k
Camilla Schou Andersen Denmark 9 246 1.7× 17 0.2× 43 0.4× 107 1.1× 104 1.2× 9 767
Teresa Adeltoft Ajslev Denmark 12 263 1.8× 18 0.2× 46 0.4× 111 1.2× 83 0.9× 20 745
Robyn Maude New Zealand 12 296 2.0× 79 0.7× 13 0.1× 123 1.3× 109 1.2× 29 808
Ali Fokar United States 10 56 0.4× 73 0.7× 37 0.4× 40 0.4× 182 2.0× 16 400

Countries citing papers authored by Carlos Jiménez-Gutiérrez

Since Specialization
Citations

This map shows the geographic impact of Carlos Jiménez-Gutiérrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Jiménez-Gutiérrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Jiménez-Gutiérrez more than expected).

Fields of papers citing papers by Carlos Jiménez-Gutiérrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Jiménez-Gutiérrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Jiménez-Gutiérrez. The network helps show where Carlos Jiménez-Gutiérrez may publish in the future.

Co-authorship network of co-authors of Carlos Jiménez-Gutiérrez

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Jiménez-Gutiérrez. A scholar is included among the top collaborators of Carlos Jiménez-Gutiérrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Jiménez-Gutiérrez. Carlos Jiménez-Gutiérrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hirsch, Sandra, et al.. (2024). Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial. SHILAP Revista de lepidopterología. 2. 1296048–1296048. 4 indexed citations
2.
Jiménez-Gutiérrez, Carlos, et al.. (2023). Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?. Hepatology International. 18(1). 168–178. 48 indexed citations
3.
Gutiérrez‐Castrellón, Pedro, A.T. Abreu y Abreu, Irma Jiménez–Escobar, et al.. (2022). Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 14(1). 2018899–2018899. 132 indexed citations breakdown →
4.
Jiménez–Escobar, Irma, Luis Hernández, Ana A. Ortiz‐Hernández, et al.. (2021). Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial. Beneficial Microbes. 12(2). 137–146. 12 indexed citations
5.
Gutiérrez‐Castrellón, Pedro, et al.. (2020). Recomendaciones sobre la utilización de las fórmulas infantiles con proteína aislada de soya en la alimentación del lactante. Documento de posición basado en la evidencia. Gaceta Médica de México. 155(92). S1–S30. 3 indexed citations
6.
Lee, Sherman A., et al.. (2020). Coronaphobia among healthcare professionals in Mexico: A psychometric analysis. Death Studies. 46(2). 280–289. 50 indexed citations
7.
Fajardo-Dolci, Germán, et al.. (2018). [Rhino-Orbital Mucormycosis. Cohort study of its treatment according disease extent and reversion of its pathophysiology].. PubMed. 152(6). 770–782. 1 indexed citations
8.
Gutiérrez‐Castrellón, Pedro, et al.. (2017). Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic. Medicine. 96(51). e9375–e9375. 47 indexed citations
10.
Gutiérrez‐Castrellón, Pedro, et al.. (2015). [Efficacy of racecadotril vs. smectite, probiotics or zinc as an integral part of treatment of acute diarrhea in children under five years: A meta-analysis of multiple treatments].. PubMed. 151(3). 329–37. 6 indexed citations
11.
López‐Velázquez, Gabriel, De Ji, Itzhel García‐Torres, et al.. (2015). Effects of Fructans from Mexican Agave in Newborns Fed with Infant Formula: A Randomized Controlled Trial. Nutrients. 7(11). 8939–8951. 22 indexed citations
12.
Gutiérrez‐Castrellón, Pedro, et al.. (2014). Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled Trial. PEDIATRICS. 133(4). e904–e909. 79 indexed citations
13.
Jiménez-Gutiérrez, Carlos, et al.. (2014). Death receptor 5 expression is inversely correlated with prostate cancer progression. Molecular Medicine Reports. 10(5). 2279–2286. 15 indexed citations
14.
Rodríguez-Ventura, Ana Lilia, Ingris Peláez‐Ballestas, Reyna Sámano, Carlos Jiménez-Gutiérrez, & Carlos A. Aguilar‐Salinas. (2014). Barriers to Lose Weight from the Perspective of Children with Overweight/Obesity and Their Parents: A Sociocultural Approach. Journal of Obesity. 2014. 1–7. 23 indexed citations
15.
Gutiérrez‐Castrellón, Pedro, et al.. (2007). Immune response to nucleotide-supplemented infant formulae: systematic review and meta-analysis. British Journal Of Nutrition. 98(S1). S64–S67. 29 indexed citations
16.
Galván-Portillo, Marcia, Carlos Jiménez-Gutiérrez, Luisa Torres‐Sánchez, & Lizbeth López‐Carrillo. (2002). Food consumption and adipose tissue DDT levels in Mexican women. Cadernos de Saúde Pública. 18(2). 447–452. 20 indexed citations
17.
Jiménez-Gutiérrez, Carlos, et al.. (1999). Lead exposure in children from 6 to 12 years old. Salud Pública de México. 41. 11 indexed citations
18.
Jiménez-Gutiérrez, Carlos, et al.. (1999). [Exposure to lead among 6-12 year-old children].. PubMed. 41 Suppl 2. S72–81. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026